Under the Federal Food, Drug, and Cosmetic Act, compounding pharmacies cant generally create drugs that are essentially copies of commercially available drugs, unless the drug is on the FDAs shortage list
Dihexa is a metabolically stabilized synthetic peptide widely used in preclinical research to investigate allosteric potentiation of HGF activity, c-Met receptor activation, synaptogenesis, and neuroregenerative signaling
So it shouldnt be a surprise to anybody
An important disadvantage concerning treatment is the side effects burden associated with current treatments
Your healthcare provider monitors your responseweight loss progress, side effect tolerance, and metabolic markersto determine if dose increases are appropriate